Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 239

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 239
---
 at $528.00 per share. Additionally, on 
 October 1, 2024, Mr. Atwood received options to purchase 5,080 shares of common stock at $10.00 per share. On October 1,             
 2024, the options granted in April 2024 were canceled pursuant to an agreement between Mr. Atwood and the Company.                   |

| (5) | In April 2024, Dr. Corey received stock options                                                                          
 to purchase 8,567 shares of common stock at $177.00 per share. Upon his resignation, all unvested options were canceled. |

| (6) | In April 2024, Mr. Carter received stock options                                                                                              
 to purchase 3,954 shares of common stock at $177.00 per share. Upon his resignation, all unvested options were canceled upon his resignation. |

| (7) | On October 1, 2024, Mr. Kucharchuk received stock                     
 options to purchase 5,000 shares of common stock at $10.00 per share. |

| (8) | In April 2024, Dr. Pierce received stock options                                                                                
 to purchase 659 shares of common stock at $36.00 per share. Additionally, on October 1, 2024, Dr. Pierce received stock options 
 to purchase 2,000 shares of common stock at $10.00 per share.                                                                   |

Narrative Disclosure to the 2024 Summary Compensation Table Compensation of our named executive officer for the fiscal year ended December 31, 2024 was determined and recommended by the compensation committee, and approved by the board of directors. The compensation committee engaged a compensation consulting firm to provide and structure benchmarking data for similar positions in similar companies. 2024 Base Salaries The named executive officers’ base salaries are a fixed component of annual compensation for performing specific duties and functions. Such base salaries are adjusted from time to time to realign with market levels after taking into account individual responsibilities, performance and experience. Annual Bonuses We use annual cash incentive bonuses for the named executive officers to motivate their achievement of short-term performance goals and tie a portion of their cash compensation to performance. It is expected that, near the beginning of each year, the Compensation Committee will select the performance targets, target amounts, target award opportunities and other terms and conditions of annual cash bonuses for the named executive officers, subject to the terms of their employment agreements. Following the end of each year, the